chrisvoncsefalvay/vaers-outcomes huggingface dataset:
18 hours after injection: shaking chills, sweats, headache, sinus pain and fatigue laste 12 hours (the last 5 of which i slept through) -all gone after 12 hours with no remnant symptoms
Patient developed a rash over upper part of her body (arms/chest).  She described rash as a "measle like" rash.  Pharmacy team was made aware of reaction to initial vaccine when they reached out to patient about receiving her second dose in the series.  Patient still wanted to receive second dose.  Patient was instructed to take Claritin and Benadryl before and after receiving vaccine.  After speaking with patient today (5/8/19) she reported she developed same rash the day after the vaccine was administered but had seen improvement.
Approximately 2.5 minutes post vaccination- patient became diaphoretic, pale, and exhibited a flat affect. Upon opening his car door to further assess, client began to jerk and froth at the mouth. Event lasted <30 seconds. Epi pen administered at 5:20 pm and ambulance called. B/P 88/42, P-120, R-20, SaO2- 96%. Patient evaluated by ambulance personnel, but refused transfer. His girlfriend stated that she would take him via private car to hospital. Patient strongly encouraged to go via ambulance- repeatedly refused.
She has a PMH of atrial fib, diabetes type 2, and CKD III. She has complaints of shortness of breath, cough, and right hip pain that started 2 days before admission. She was tested for COVID and was positive. She was admitted requiring supplemental oxygen and acute oxygen and acute exacerbation of chronic heart failure.
Initial and follow up information has been received from a medical assistant concerning a 65 yr old white female with a resolving vesicular rash, cardiac disorder, and an allergy to Tolech who on 21Sep05, at approx 9:30AM, was vaccinated IM in the left deltoid with a 0.5ml dose of pneumococcal 23v polysaccharide vaccine (lot 650083/0746P). It was reported that the pt was vaccinated with a prior dose of pneumococcal 23v polysaccharide vaccine on 10Sep68 (approved for market 07Jul83). Concomitant therapy included atenolol, aspirin, alendronate sodium and rabeprazole sodium (Aciphex). On the pt's drive home after vaccination, on 21Sep05, the pt felt nauseous, pale, sweaty and developed a lump at the injection site. In follow up, it was reported that at approx 9:45AM on 21Sep05, the pt got pale, sweats, and nauseous, with redness at injection site and a definite lump. The pt did not develop any itching. On 22Sep05, the pt reported the event to the physician's office, and also reported that she was feeling better, although, the lump and redness were still present. By the afternoon of 22Sep05, the pt was recovered. A concern regarding the lot was expressed by the reporter. No further information is expected. The records of testing prior to release of this lot have been checked by QA and found to be satisfactory. The lot complies with the standards and was released.
No additional adverse events reported; The patient was administered with improperly stored vaccine; This spontaneous report was received from a licensed practical nurse referring to a patient of unknown age and gender. Information about the patient's concurrent conditions, medical history, drug reactions/allergies and concomitant therapies was not reported.   On 31-DEC-2021, the patient was vaccinated with improperly stored measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (recombinant Human albumin (rHA)) (M-M-R II) (lot# T033815, expiration date 05-OCT-2022; strength, dose and route were not reported) for prophylaxis (product storage error).  The administered vaccine experienced a temperature excursion in 49.6 Fahrenheit degrees (F) for 35 hours 9 minutes. The previous temperature excursions included 32.9 F for 53 hours 16 minutes, 49.1 F for 5 hours 9 minutes, and 56.3 F for 14 hours 7 minutes. No additional adverse events reported.   This is one of multiple cases received from the same reporter.; Sender's Comments:  US-009507513-2203USA003310: US-009507513-2203USA003311: US-009507513-2203USA003312: US-009507513-2203USA003313: US-009507513-2203USA003314: US-009507513-2203USA003315: US-009507513-2203USA003316: US-009507513-2203USA003318: US-009507513-2203USA003319: US-009507513-2203USA003320: US-009507513-2203USA003321: US-009507513-2203USA003322: US-009507513-2203USA003323: US-009507513-2203USA003324: US-009507513-2203USA003325: US-009507513-2203USA003326: US-009507513-2203USA003327: US-009507513-2203USA003328: US-009507513-2203USA003329: US-009507513-2203USA003330: US-009507513-2203USA003331: US-009507513-2203USA003332: US-009507513-2203USA003333: US-009507513-2203USA003334: US-009507513-2203USA003335: US-009507513-2202USA003592:
Injection site itchy, red, swollen (got vaccine on 6/7/17 symptoms started on the 8th she called us the 9th) she went to urgent care. Dx= histamine reaction use BENADRYL cream, ice. They Rx KEFLEX PRN if got worse.
This spontaneous report was received from a pharmacist refers to a 52 year old female patient. The patient did not have pertinent medical history, drug reactions/allergies and concomitant medications. On an unknown date, the patient was vaccinated with M-M-R II as vaccination (dosing details, route, lot# and expiration date not reported). On an unknown date, post vaccination an unspecified test showed a low serologic titer. The patient sought medical attention and received treatment for the event. The event did not cause hospitalization or disability to the patient. The event was not life threatening. The outcome of the event viral titer decreased was unknown. The reporter's causality assessment was not provided. Product quality complaint not involved.
Patient fainted 5 minutes after getting first dose of Covid 19 vaccine.  Patient regained consciousness after 5 seconds and had full cognition.  She was able to answer questions fully about activities up to that point in the day and knew what she had to breakfast.  Patient was asked to wait around for 30 more minutes for monitoring and walked out of store unassisted after this time had passed.
her arm hurt with the previous doses too; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  An 83-year-old female patient received bnt162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown), in arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 2, SINGLE, Unknown manufacturer), for COVID-19 immunization; Bnt162b2 (DOSE 1, SINGLE, Unknown manufacturer), for COVID-19 immunization. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "her arm hurt with the previous doses too".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300348067 Same patient, different vaccine dose number, different AE;
This spontaneous report as received from a nurse refers to a patient of unknown age. The patient was vaccinated with dose 1 GARDASIL on 2010 (lot# and dose not reported) and the second dose of GARDASIL (lot# and dose not reported) on 22-AUG-2012. No adverse effect reported. Additional information has been requested.
Shortly after the vaccine I had total body itching and a very runny nose.  I had chosen to change allergy medicine from Zyrtec and thought this might be the cause.  I then experienced severe itching of my left leg which, has more varicose veins than the R.  The veins were distended.  Compression socks were helpful.  I recognized discomfort in my chest, maybe flutters or pinching sensation , but brushed it off as reaction to coming off Zyrtec.    More concerning is realizing I may have experienced a decerebrate posture ( I am a retired Occupational Therapist).  I woke one night with my neck extended, a position I avoid due to pinched nerves in my neck.  My hands were fisted with thumbs tight in the palms.  I had unusual red marks on one inner thigh and one upper arm.  These are places my fingers often rest when I sleep.  I did experience tension in my neck and back of head that might be considered a headache for a week or so.  I feel I may have had mental fogging as I did not take it seriously .  My cardiologist recommended reporting to this site.
This spontaneous report as received from a clinic manager refers to an unspecified patients of unknown age and gender. On an unknown date, the patients were vaccinated with improperly stored doses of PNEUMOVAX23 (dose, route of administration and lot numbers were not reported). The reporter was not aware of an adverse experience. There was no previous temperature excursion. The call was made because of data logger. Administered vaccine experienced the temperature excursion of 32 to 35 degrees Fahrenheit for 15 hours. Data logger was involved. This is one of several reports received from the same reporter. Additional information has been requested.  ; Sender's Comments: US-009507513-1705USA012739: US-009507513-1705USA012738: US-009507513-1705USA012737:
11/8/10 Well check. Mild nasal congestion. Received DTaP/IPV/Hep B #1, ROTARIX #1. 11/15/10 Nasal congestion. Parents concerned about wheezing. Seen in office. T dx with URI. Stools decreased in frequency and color/odor change per mother. This began within 24-36 hours. Eyes red. 11/17/10 Blood in seedy stool with mucus. Stool culture done. Had had 1 previous bloody stool. 11/19/10 Decreased stooling (neg for blood). Nasal congestion/upper airway stridor. 11/21/10 (+) Salmonella. Admitted to hosp for stridor. 11/23/10 Sub laryngeal cysts x 3 removed.
Patient was given the Pfizer bivalent booster product instead of the intended Moderna bivalent booster product (previous vaccinations were Moderna).
Approximately 5 minutes after patient was vaccinated patient stood up and warned to staff technician that they were having a reaction. Patient then slightly stumbled as if they were about to faint. Staff technician caught patient by the arm and staff pharmacist helped bring patient slowly to the ground to lay flat. Patient noted no signs of difficulty breathing, throat closing or other respiratory symptoms. Patient breathing improved per patient once he was down on the floor and noted that while he was fallling he slightly lost consciousness.  Local Fire department came to the scene and assessed patient's blood pressure and pulse oximetry. Patient BP remained stable at 115/81 while both laying flat, sitting on a chair, and standing up straight upon firefighter instruction. Paramedics were cancelled and patient opted and signed to drive himself home. Staff pharmacist persuaded patient to stay another 10 minutes after firefighters left to be monitored.
12/4/21:  Presented to ER with complaints of nausea/vomiting, decreased PO intake X6 days; body aches, cough/SOB, and generalized weakness.  Had a known COVID+ exposure on 11/23/21 from family.  Tested COVID+ on admission.  K3.2, WBC 5.0, Lactic acid 1.7.  HR 80s, RR 16-20, sat 100% on RA at rest down to 93% on RA with activity, BP 170/90, afebrile.  CXR linear opacities within lung bases.  CT negative for PE showing bilateral infiltrates consistent with COVID.  Admit with COVID 19 PNA.  Started on IV azithromycin, IV ceftriaxone, PO prednisone, remdesivir, Lovenox, and zofran. 12/7/21:  Uneventful hospitalization.  Remained afebrile and sat maintained >92% on RA throughout stay.  Discharged home.
pt recvd vax & adm dx failure to thrive, dehydration, metabolic acidosis, thrombocytopenia, erythema multiforme;devel dec in appetite, lethargic, rash devel, nasal discharge, appeared wasted & lethargic, weight 7lb 8oz;dec tone;
feeling weak; fever; cough; congestion; sick; he is now Covid positive; he is now Covid positive; This is a spontaneous report from a contactable pharmacist (parent). A 17-years-old male patient (son) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Lot Number: EW0181, Expire Date: Unknown), via an unspecified route of administration, administered in left arm on 28Jun2021 (mid-morning) (age at vaccination: 17 years) as DOSE 2, SINGLE for covid-19 immunisation. The patient's medical history included asthma, seasonal allergy, environmental allergies. SARS-CoV2 antibodies at diagnosis was reported as unknown. Prior Vaccinations (within 4 weeks) included had allergy shots. The patient's concomitant medications were not reported. The patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Lot Number: EW0182) via an unspecified route of administration, administered in left arm on 22May2021 (at the age of 17 years) as DOSE 1, SINGLE for covid-19 immunisation. The patient was administered vaccine in a mass vaccination site, mall. On 11Oct2021, the patient experienced was now covid positive. Patient was sick a week and a half prior to testing positive. They did a home test and it was negative. He went to the doctor's office 01Oct2021 to confirm if self home test was negative. He had a molecular test done and it was negative. All of his symptoms at that time had gone away except the cough. Then symptoms came back. He had a fever on 10Oct2021 and another covid test done on 11Oct2021 and it came back as positive. On an unknown date, the patient was feeling weak, fever, cough and congestion. She stated his is mild to moderate. He has asthma and that is why his symptoms were lingering.The patient underwent lab tests and procedures which included on an unknown date, sars-cov-2 test was negative and on 11Oct2021, sars-cov-2 test was positive. The patient did not require an emergency room visit. No additional vaccines administered on same date of the Pfizer suspect. The patient was treated for symptoms. The patient displayed clinical signs at rest indicative of severe systemic illness included fever. When patient gets sick it goes to his chest. His asthma exacerbates when he was sick. He used a steroid inhaler (Dulera) 2 puffs 2 times a day, rescue inhaler (Ventolin) 4 times in a day, allergy medicine (Zyrtec, Flonase Nasal Spray, Asteline Nasal Spray) and Tylenol for temperature and vitamins to keep immune system healthy. He only takes the inhalers when sick, it's not constant. Only when sick to keep out of his chest. On a regular basis he takes the allergy medicines. There was no product quality complaint (PQC) present.The event did not require the initiation of new medication or other treatment or procedure. patient hospitalized was reported as no. The outcome of the events was unknown.; Sender's Comments: Based on the available information in the case, the causal association between the event vaccination failure, COVID-19 and the suspect drug BNT162B2 cannot be excluded.
Had small, hard, painful knot at injection sight after shot that lasted 3 days and went away Itches, slightly tender to palpation, red 16.5 cm X 8.5 cm on R arm, anterior lateral aspect Treatment: Steroid injection - Cephalexin, Claritin, Famotidine, steroid cream - Triamcinolone, Salonpas liquid lidocaine
This case was reported by a nurse and described a 60 year old male patient who did not respond to Hep-B vaccine immunization series.    On an unspecified date in 2002 or 2003, the patient received the third dare of Energix-B.  Approximately "6 to 12 weeks" later, a Hep-B surface antibody titer was "negative".  The nurse stated that "All injections were given IM in the deltoid muscle with a 1 inch needle.  All vaccine is refrigerated and the temperature is monitored daily."  The nurse considered the event to be probably related to vaccination with Energix-B
pt recvd Engerix-B on 16JUN92 & 2 days p/vax devel hives; w/in 5 days covered w/hives; worsened everyday & pt hospitalized; also exp throat closing, dizzy, difficulty breathing, blurred vision, could not stand, pain to touch; tx pred;
Pt's wife called for husband c/o sore arm and fever; advised to go to ER if serious sx per RN; 09/09/2011; ER RN called for other ER requesting records of vaccine given becasue pt there; records sent by CPH; records from ER indicate pt came there approx 9:00AM c/o abdominal pain (pain 8 on scale 10), fever, chills, frontal h/a; per ER notes, dehydrated and given IVs; DX :"Medication reaction." Discharged "improved" at approx 5:00PM
Headache, Myalgia, Fever, Left axilla swelling, tenderness, intermittent numbness. Narrative:
Possible Carpal tunnel syndrome; inflammation everywhere in his body / inflammation in glutes, thighs, back of knees, bottom of feet, neck and shoulders; The pain in his hands ebbs and flows / pain presented in his hands and wrists; muscle aches everywhere /  The aches progressively became worse as time went on; aches are present everywhere else / aches; it feels like a storm is going on inside his body; feels burning all over his body; stomach is burning as well; This case was reported by a consumer via call center representative and described the occurrence of carpal tunnel syndrome in a 54-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Concomitant products included Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent 2019-2020 season) and Herpes zoster (Shingrix).   In October 2020, the patient received the 2nd dose of Shingrix. On an unknown date, less than 2 months after receiving Shingrix, the patient experienced carpal tunnel syndrome, inflammation, pain in hand, muscle pain, general body pain, feeling abnormal, burning sensation and stomach burning sensation of. On an unknown date, the outcome of the carpal tunnel syndrome, general body pain, feeling abnormal, burning sensation and stomach burning sensation of were unknown and the outcome of the inflammation, pain in hand and muscle pain were not recovered/not resolved.   It was unknown if the reporter considered the carpal tunnel syndrome, inflammation, pain in hand, muscle pain, general body pain, feeling abnormal, burning sensation and stomach burning sensation of to be related to Shingrix.  Additional details were provided as follows: The patient had his first dose of Shingrix in one arm and a flu shot in the other arm at the same time in August 2020.   The patient was administered the 2nd dose of Shingrix exactly 2 months after the first. The exact vaccination dates were unknown. In either October or November the patient started to feel inflammation everywhere in his body. Then pain presented in his hands and wrists followed by muscle aches everywhere. At first it was thought to be carpool tunnel syndrome.   The pain in his hands ebbs and flows but the aches were present everywhere else. The aches progressively became worse as time went on. At the time of reporting , he had aches and inflammation in glutes, thighs, back of knees, bottom of feet, neck and shoulders. He said it feels like a storm was going on inside his body. There were aches everywhere with the exception of his head and ears.   In other words, he was symptom free from the chin up. The patient stated that the patient felt burning all over his body. He stated his stomach was burning as well. The reporter consented to follow up. The pharmacist provided permission to follow up with her for additional details such as the lot numbers of both the Shingrix and the Flu vaccine.
Total amount of time the vial was exposed to room temperature range (8° to 25°C= 46° to 77°F): 25 hours and 34 minutes; Patient received expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine) and PRODUCT STORAGE ERROR (Total amount of time the vial was exposed to room temperature range (8° to 25°C= 46° to 77°F): 25 hours and 34 minutes) in a 50-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 066K21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Mar-2022 at 12:10 PM, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) .5 milliliter. On 24-Mar-2022 at 12:10 PM, after starting mRNA-1273 (Spikevax), the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Total amount of time the vial was exposed to room temperature range (8° to 25°C= 46° to 77°F): 25 hours and 34 minutes). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine) and PRODUCT STORAGE ERROR (Total amount of time the vial was exposed to room temperature range (8° to 25°C= 46° to 77°F): 25 hours and 34 minutes) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Intramuscular) was unknown.   For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported On 13-Mar-2022, the vial was initially stored in the refrigerator. On 23-Mar-2022 at 10:36 AM, the vial was first punctured. Vial was stored in room temperature post puncture and no  previous temperature excursion. Total amount of time the vial was exposed to room temperature range (8° to 25°C= 46° to 77°F) was 25 hours and 34 minutes. The vaccine bottle expired on 23-Mar-2022 at 10:36 PM. No treatment drugs were reported.
A 15-year-old patient given Moderna instead of Pfizer. Talked to patient's mom. There was no reaction to the vaccine. She is doing good, and mom is fine with Moderna.
I was fine immediately after the vaccine.  At around 9:00 pm on the night of December 23rd I noted that my eyes started to swell.  I had no difficulty  breathing, shortness of breath, closing of the throat at this time.  My husband and I decided to just take a Benadryl 25 mg by mouth and keep the Epipen close by.   I went to bed.  At around 2:30 am on December 24th  I woke up to excruciating pain but with the urge to urinate.   However, I was in so much pain at the time I did not want to get up so I tried to go back to sleep.  At 4:30 am on December 24h in the morning, I decided I needed to get up to go to the bathroom.  I went to ambulate and instantly felt weak in my knees and extremely dizzy.  I made it my bathroom and looked in the mirrors- my face was extremely pale like a sheet of paper white, I was really nauseous, dizzy, felt the urge to have a bowel movement.  I walked to the bathroom.  I was able to void at that time, but the nausea did not go away.  I crawled to my bed and laid back down.  I then still felt intensely nauseous to the point that I was going to pass out and the room was spinning.  I made it back to the bathroom where I threw bile up in the bathroom.  I still had the urge for a bowel movement but was unable to go ( I imagine I was having a vasovagal response).  I went back to my bed and laid down.  I stayed in bed until my husband came down around 8:30.  He told me to drink some fluids and take another benadryl  with some tylenol.  I did both.  I went back to sleep and I woke up about 2.5 hours later.  I was able to go out of the house to get a few things for Christmas, but then about 6 pm went and laid down for bed for the night.  I took another benadryl and more tylenol.   On 12/25/2020 I woke up and was able to do a few things thanks to tylenol and benadryl.  My eyes were still swollen and now my hands and feet were noticeably swollen. I continued with benadryl, tylenol and started taking pepcid 10 mg PO.  By Saturday 12/26/2020, I was able to be more mobile- I was able to walk the dog and clean my car.  However, I still went to bed rather early.  I took another benadryl and tylenol as I still felt swollen and puffy all over.  Up until Monday 12/28/2020 I had a constant headache and felt nausesous with some swelling.  I have not went to a physician to be seen. I have talked to several physicians, as I am an RN and my husband is an ER physcian.  Yesterday 12/29/2020 was the first time I felt normal since the vaccine.